Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Clinical trial NCT02276820 · WITHDRAWN

Trial details

NCT number: NCT02276820
Sponsor: AlloVir
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Adenovirus Infection

Start date: 2017-12-07
Primary completion: 2018-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.